Global Bi-Specific Antibodies Therapy Competitive Landscape Professional Research Report 2024
Research Summary
Bi-specific antibody therapy is a type of immunotherapy that harnesses the power of antibodies to target and treat diseases. Bi-specific antibodies are engineered molecules that can simultaneously bind to two different target molecules. They are designed to recognize a specific antigen expressed on the surface of diseased cells or pathogens, such as cancer cells or viruses, while also engaging with immune cells or other components of the immune system. By binding to both the target and the immune cells, bi-specific antibodies bring them into close proximity, facilitating immune responses against the targeted cells. This approach enhances the specificity and potency of the immune response, leading to enhanced destruction of diseased cells or improved neutralization of pathogens. Bi-specific antibody therapy has shown promise in the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases, and it continues to be an active area of research and development in the field of immunotherapy.
According to DIResearch's in-depth investigation and research, the global Bi-Specific Antibodies Therapy market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Bi-Specific Antibodies Therapy include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, AstraZeneca, AbbVie, Lindis Biotech, MacroGenics, Genmab, Alphamab, Akeso etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Bi-Specific Antibodies Therapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Bi-Specific Antibodies Therapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Bi-Specific Antibodies Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bi-Specific Antibodies Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Bi-Specific Antibodies Therapy Include:
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics
Genmab
Alphamab
Akeso
Bi-Specific Antibodies Therapy Product Segment Include:
Fragment-Based Antibodies
IgG-Based Antibodies
Bi-Specific Antibodies Therapy Product Application Include:
Cancer
Haemophilia
Other Non-Cancer Diseases
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Bi-Specific Antibodies Therapy Industry PESTEL Analysis
Chapter 3: Global Bi-Specific Antibodies Therapy Industry Porter’s Five Forces Analysis
Chapter 4: Global Bi-Specific Antibodies Therapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global Bi-Specific Antibodies Therapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Bi-Specific Antibodies Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Bi-Specific Antibodies Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Bi-Specific Antibodies Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Bi-Specific Antibodies Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Bi-Specific Antibodies Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Bi-Specific Antibodies Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Bi-Specific Antibodies Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Bi-Specific Antibodies Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Bi-Specific Antibodies Therapy Product by Type
- 1.2.1 Global Bi-Specific Antibodies Therapy Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Fragment-Based Antibodies
- 1.2.3 IgG-Based Antibodies
- 1.3 Bi-Specific Antibodies Therapy Product by Application
- 1.3.1 Global Bi-Specific Antibodies Therapy Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Cancer
- 1.3.3 Haemophilia
- 1.3.4 Other Non-Cancer Diseases
- 1.4 Global Bi-Specific Antibodies Therapy Market Revenue Analysis (2019-2030)
- 1.5 Bi-Specific Antibodies Therapy Market Development Status and Trends
- 1.5.1 Bi-Specific Antibodies Therapy Industry Development Status Analysis
- 1.5.2 Bi-Specific Antibodies Therapy Industry Development Trends Analysis
- 2 Bi-Specific Antibodies Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Bi-Specific Antibodies Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Bi-Specific Antibodies Therapy Market Analysis by Regions
- 4.1 Bi-Specific Antibodies Therapy Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Bi-Specific Antibodies Therapy Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Bi-Specific Antibodies Therapy Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Bi-Specific Antibodies Therapy Revenue Forecast by Region (2025-2030)
- 5 Global Bi-Specific Antibodies Therapy Market Size by Type and Application
- 5.1 Global Bi-Specific Antibodies Therapy Market Size by Type
- 5.2 Global Bi-Specific Antibodies Therapy Market Size by Application
- 6 North America
- 6.1 North America Bi-Specific Antibodies Therapy Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Bi-Specific Antibodies Therapy Market Size by Type
- 6.4 North America Bi-Specific Antibodies Therapy Market Size by Application
- 6.5 North America Bi-Specific Antibodies Therapy Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Bi-Specific Antibodies Therapy Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Bi-Specific Antibodies Therapy Market Size by Type
- 7.4 Europe Bi-Specific Antibodies Therapy Market Size by Application
- 7.5 Europe Bi-Specific Antibodies Therapy Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Bi-Specific Antibodies Therapy Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Bi-Specific Antibodies Therapy Market Size by Type
- 8.4 China Bi-Specific Antibodies Therapy Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Bi-Specific Antibodies Therapy Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Bi-Specific Antibodies Therapy Market Size by Type
- 9.4 APAC (excl. China) Bi-Specific Antibodies Therapy Market Size by Application
- 9.5 APAC (excl. China) Bi-Specific Antibodies Therapy Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Bi-Specific Antibodies Therapy Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Bi-Specific Antibodies Therapy Market Size by Type
- 10.4 Latin America Bi-Specific Antibodies Therapy Market Size by Application
- 10.5 Latin America Bi-Specific Antibodies Therapy Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Type
- 11.4 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Application
- 11.5 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Bi-Specific Antibodies Therapy Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Bi-Specific Antibodies Therapy Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Bi-Specific Antibodies Therapy Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Roche
- 13.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Roche Bi-Specific Antibodies Therapy Product Portfolio
- 13.1.3 Roche Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Amgen
- 13.2.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Amgen Bi-Specific Antibodies Therapy Product Portfolio
- 13.2.3 Amgen Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Sanofi
- 13.3.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Sanofi Bi-Specific Antibodies Therapy Product Portfolio
- 13.3.3 Sanofi Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Pfizer
- 13.4.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Pfizer Bi-Specific Antibodies Therapy Product Portfolio
- 13.4.3 Pfizer Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Johnson & Johnson
- 13.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Johnson & Johnson Bi-Specific Antibodies Therapy Product Portfolio
- 13.5.3 Johnson & Johnson Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 AstraZeneca
- 13.6.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 AstraZeneca Bi-Specific Antibodies Therapy Product Portfolio
- 13.6.3 AstraZeneca Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 AbbVie
- 13.7.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 AbbVie Bi-Specific Antibodies Therapy Product Portfolio
- 13.7.3 AbbVie Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 Lindis Biotech
- 13.8.1 Lindis Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Lindis Biotech Bi-Specific Antibodies Therapy Product Portfolio
- 13.8.3 Lindis Biotech Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 MacroGenics
- 13.9.1 MacroGenics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 MacroGenics Bi-Specific Antibodies Therapy Product Portfolio
- 13.9.3 MacroGenics Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 Genmab
- 13.10.1 Genmab Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Genmab Bi-Specific Antibodies Therapy Product Portfolio
- 13.10.3 Genmab Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 Alphamab
- 13.11.1 Alphamab Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Alphamab Bi-Specific Antibodies Therapy Product Portfolio
- 13.11.3 Alphamab Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.12 Akeso
- 13.12.1 Akeso Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Akeso Bi-Specific Antibodies Therapy Product Portfolio
- 13.12.3 Akeso Bi-Specific Antibodies Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Bi-Specific Antibodies Therapy Industry Chain Analysis
- 14.2 Bi-Specific Antibodies Therapy Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Bi-Specific Antibodies Therapy Typical Downstream Customers
- 14.4 Bi-Specific Antibodies Therapy Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook